Literature DB >> 11701760

Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse.

E M Ingram1, J W Wiseman, S Tessler, P C Emson.   

Abstract

There is extensive experimental evidence indicating a crucial role for glutamate in epileptogenesis and epileptic activity. The glial glutamate transporters GLT1 and GLAST are proposed to account for the majority of extracellular glutamate re-uptake. In the present study, polyclonal antibodies specific to GLT1 and GLAST were generated and characterized, revealing distribution patterns for the two transporters confirming those previously reported. In situ hybridization and immunoblotting were then used to compare levels of these two transporters in the parietal cortex and hippocampus of unstimulated and stimulated EL mice with DDY control mice. Additionally, HPLC determined tissue glutamate concentrations in the same regions of these animals. These experiments revealed reductions in GLT1 mRNA and protein in the parietal cortex of unstimulated and stimulated EL mice compared with DDY controls, accompanied by an increase in tissue glutamate concentration in the stimulated EL mice group. GLT1 mRNA was also reduced in the CA3 hippocampal subfield of both unstimulated and stimulated EL mice. GLAST protein was reduced in the hippocampus of the stimulated EL mice group, while no changes in GLAST mRNA or protein were detected in the parietal cortex of EL mice when compared with DDY controls. The glial glutamate transporter down-regulation reported here may play a role in seizure initiation, spread and maintenance in the EL mouse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701760     DOI: 10.1046/j.1471-4159.2001.00612.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Brain endothelial cells induce astrocytic expression of the glutamate transporter GLT-1 by a Notch-dependent mechanism.

Authors:  Meredith L Lee; Zila Martinez-Lozada; Elizabeth N Krizman; Michael B Robinson
Journal:  J Neurochem       Date:  2017-09-05       Impact factor: 5.372

2.  Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion.

Authors:  X Wu; T Kihara; H Hongo; A Akaike; T Niidome; H Sugimoto
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester.

Authors:  Bala T S Susarla; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-09-06       Impact factor: 3.921

Review 4.  Mitochondria, oxidative stress, and temporal lobe epilepsy.

Authors:  Simon Waldbaum; Manisha Patel
Journal:  Epilepsy Res       Date:  2009-10-21       Impact factor: 3.045

Review 5.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

6.  Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.

Authors:  Ling-Hui Zeng; Adam W Bero; Bo Zhang; David M Holtzman; Michael Wong
Journal:  Neurobiol Dis       Date:  2010-01-04       Impact factor: 5.996

7.  A proposal of a novel experimental procedure to genetically identify disease gene loci in humans.

Authors:  Taro Muto
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 8.  Neurological diseases as primary gliopathies: a reassessment of neurocentrism.

Authors:  Alexei Verkhratsky; Michael V Sofroniew; Albee Messing; Nihal C deLanerolle; David Rempe; José Julio Rodríguez; Maiken Nedergaard
Journal:  ASN Neuro       Date:  2012-04-05       Impact factor: 4.146

Review 9.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice.

Authors:  Louisa Lyon; James N C Kew; Corrado Corti; Paul J Harrison; Philip W J Burnet
Journal:  Synapse       Date:  2008-11       Impact factor: 2.562

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.